Myasthenia gravis is an autoimmune neuromuscular disorder. There are several 
treatment options, including symptomatic treatment (acetylcholinesterase 
inhibitors), short-term immunosuppression (corticosteroids), long-term 
immunosuppression (azathioprine, cyclosporine, cyclophosphamide, methotrexate, 
mycophenolate mofetil, rituximab, tacrolimus), rapid acting short-term 
immunomodulation (intravenous immunoglobulin, plasma exchange), and long-term 
immunomodulation (thymectomy). This review explores in detail these different 
treatment options. Potential future treatments are also discussed.